CytoSorbents effects 1-for-20 reverse stock split to lift Nasdaq bid price above $1 - CTSO News | RalliesCytoSorbents effects 1-for-20 reverse stock split to lift Nasdaq bid price above $1
C
CTSO• CytoSorbents to implement 1-for-20 reverse stock split
- CytoSorbents to implement a 1-for-20 reverse stock split, effective Sept. 8, 2026.
- Shares to trade on a split-adjusted basis at the Sept. 8 market open under CTSO.
- Move targets Nasdaq’s $1 minimum bid-price rule for continued listing.
- Outstanding share count expected to drop to about 3,151,101 from 63,022,020, excluding rounding effects.
- Options and warrants to be adjusted proportionately, including exercise prices.
LUCY
•
